Gary Friedman, MD, the Division of Research’s 3rd director, passed away the weekend of July 18. Born in 1934, he began at DOR in 1968, serving as DOR director from 1991 to 1998 before retiring in 1999
New Kaiser Permanente study one of first to show novel coronavirus impact on cancer detection.
Kaiser Permanente researchers will study the drug Vascepa in people 50 and older with heart disease.
Virtual, innovative COVID-19 prevention trial now enrolling high-risk adults
Fewer endometrial cancer diagnoses made during COVID-19 pandemic
Gary Friedman, MD, MS, 1934 – 2020
Early colorectal cancer screening benefits African Americans
Kaiser Permanente researchers develop new prostate cancer risk calculator
Trump's praise of hydroxychloroquine led to a boom in prescriptions. Then came reports of thousands of patients experiencing adverse events.
Asthma common among children with autism, developmental disabilities
How breastfeeding protects mothers
Research sheds light on changes in PrEP use over time in San Francisco and Australia
Long-term PrEP continuum of care patterns